fbpx
X

Quality Statement

Pacific Biosciences is committed to providing high-quality products that meet customer expectations and comply with regulations. We will achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product quality, performance, and safety.

X

Image Use Agreement

By downloading, copying, or making any use of the images located on this website (“Site”) you acknowledge that you have read and understand, and agree to, the terms of this Image Usage Agreement, as well as the terms provided on the Legal Notices webpage, which together govern your use of the images as provided below. If you do not agree to such terms, do not download, copy or use the images in any way, unless you have written permission signed by an authorized Pacific Biosciences representative.

Subject to the terms of this Agreement and the terms provided on the Legal Notices webpage (to the extent they do not conflict with the terms of this Agreement), you may use the images on the Site solely for (a) editorial use by press and/or industry analysts, (b) in connection with a normal, peer-reviewed, scientific publication, book or presentation, or the like. You may not alter or modify any image, in whole or in part, for any reason. You may not use any image in a manner that misrepresents the associated Pacific Biosciences product, service or technology or any associated characteristics, data, or properties thereof. You also may not use any image in a manner that denotes some representation or warranty (express, implied or statutory) from Pacific Biosciences of the product, service or technology. The rights granted by this Agreement are personal to you and are not transferable by you to another party.

You, and not Pacific Biosciences, are responsible for your use of the images. You acknowledge and agree that any misuse of the images or breach of this Agreement will cause Pacific Biosciences irreparable harm. Pacific Biosciences is either an owner or licensee of the image, and not an agent for the owner. You agree to give Pacific Biosciences a credit line as follows: "Courtesy of Pacific Biosciences of California, Inc., Menlo Park, CA, USA" and also include any other credits or acknowledgments noted by Pacific Biosciences. You must include any copyright notice originally included with the images on all copies.

IMAGES ARE PROVIDED BY Pacific Biosciences ON AN "AS-IS" BASIS. Pacific Biosciences DISCLAIMS ALL REPRESENTATIONS AND WARRANTIES, EXPRESS, IMPLIED OR STATUTORY, INCLUDING, BUT NOT LIMITED TO, NON-INFRINGEMENT, OWNERSHIP, MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. IN NO EVENT SHALL Pacific Biosciences BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES OF ANY KIND WHATSOEVER WITH RESPECT TO THE IMAGES.

You agree that Pacific Biosciences may terminate your access to and use of the images located on the PacificBiosciences.com website at any time and without prior notice, if it considers you to have violated any of the terms of this Image Use Agreement. You agree to indemnify, defend and hold harmless Pacific Biosciences, its officers, directors, employees, agents, licensors, suppliers and any third party information providers to the Site from and against all losses, expenses, damages and costs, including reasonable attorneys' fees, resulting from any violation by you of the terms of this Image Use Agreement or Pacific Biosciences' termination of your access to or use of the Site. Termination will not affect Pacific Biosciences' rights or your obligations which accrued before the termination.

I have read and understand, and agree to, the Image Usage Agreement.

I disagree and would like to return to the Pacific Biosciences home page.

Pacific Biosciences
Contact:

Customer Success Story

How SMRT Sequencing Helped Researchers at University of Washington Uncover a Tandem Repeat Linked to ALS

PacBio long-read sequencing removes the barrier of sequencing long tandem repeats found to be linked to ALS.

  1. The Problem
    More than 40 tandem repeat expansions in the human genome are known to cause neurological disease. Short-read sequencing cannot capture these large repeat expansions, causing them to be missed in many studies.
  2. The Solution
    Highly accurate long-read sequencing (HiFi sequencing) allows scientists to capture the full range of genomic variation - even in challenging regions of the genome like large repeat expansions.
  3. The Result
    Through HiFi sequencing, researchers pinpointed a 69-bp VNTR in the WDR7 gene that was found to be enriched in three independent cohorts in individuals with ALS.

ALS at a Glance

 

Currently, the causes of ALS are largely unknown. Could the missing heritability be explained by complex genomic variants that are not captured with genotyping or short-read sequencing methods?
*in the United States

Uncovering a Genetic Variant Linked to ALS

A serendipitous discovery led University of Washington scientists to a tandem repeat that appears to explain some cases of sporadic amyotrophic lateral sclerosis, or ALS. This adds to the growing number of neurological diseases associated with tandem repeats, and provides a promising new path for identifying people at risk of developing ALS.

This discovery began with scientists interested in learning more about variable number tandem repeats (VNTRs). Paul Valdmanis (@pvaldmanis), assistant professor of medical genetics, and Meredith Course, a postdoctoral fellow in his lab, were pursuing the genetic cause of ALS in a large multigenerational family with several members who had developed the disease. That work pointed them toward a region on chromosome 18 that included a known tandem repeat, seen in a fairly expanded state in affected family members.

Multi-generational Family With ALS Affected Members

HiFi Long-Read Sequencing

VNTRs present a serious technical challenge for scientists. These elements can be extremely long, and with their repetitive nature, it is impossible to characterize them accurately using short-read sequencing technology and the necessary post-sequencing alignment process.

 

Benefits of Long-Read Sequencing

Highly accurate long reads, or HiFi reads, have allowed scientists to sequence through these challenging regions, base by base, for the most comprehensive and complete representation of even very large repeat expansions. Also known as Single Molecule, Real-Time (SMRT) Sequencing, this technology has shed light on repeat-associated neurological diseases such as fragile X syndrome, ataxias, and more. These discoveries clearly show that both the number of repeats and any tough-to-spot base interruptions in the region can be essential to understanding which people may develop a disease and which may not.

Course and Valdmanis chose to implement SMRT Sequencing for their ALS study and wound up revealing far more than they expected. “Once we decided to pursue long-read sequencing, we were really surprised to see the patterns that arose,” Course says.

What long-read sequencing gives us is the internal nucleotide structure. That’s just unprecedented, and it’s extremely valuable.
Meredith Course, Ph.D.
Research Fellow, University of Washington

Study Highlights

The scientists focused on a gene called WDR7, where a large, 69-base intronic repeat appeared to meet their criteria for a possible mechanism associated with spontaneous ALS. In the affected family, people with ALS had about 27-33 copies of the tandem repeat.

Using a multiplexed sequencing strategy with barcoded amplicons, the team pooled nearly 300 samples and analyzed the WDR7 gene in each.

The VNTR was not what they anticipated. “We call it a living, breathing repeat,” Valdmanis adds. “It was actually growing in one direction. As it’s building, it’s adding these new repeat units, two at a time.”

VNTRs

We really couldn’t get at this by PCR or Sanger sequencing. It was only when we started to do this multiplexed long-read sequencing approach that we could see the samples fell into this structured, clear pattern.
Paul Valdmanis, Ph.D.
Assistant Professor of Medical Genetics, University of Washington

With SMRT Sequencing, the scientists had no trouble getting an accurate count of the repeat in each sample. Perhaps more importantly, they were able to identify six of the 69 bases that varied across the repeat expansion. Those bases, and only those bases, changed across the entire VNTR. What they discovered was a clear pattern of variability or ‘interruption sequences’. “That gave us confidence that we had a very accurate method to call these nucleotides across the repeat,” Valdmanis says.

“With most research in tandem repeats, what they’re measuring is the length of the repeat,” says Course. “What long-read sequencing gives us is the internal nucleotide structure. That’s just unprecedented, and it’s extremely valuable.”

An in-depth investigation found that each repeat unit forms a structure that has the potential to produce microRNAs, as the scientists report in their publication in the American Journal of Human Genetics.

SNPs

The team could have stopped there, but instead pressed on to learn more about this intriguing tandem repeat. They used data from the 1,000 Genomes Project to chart patterns of the VNTR across geographic populations, finding that not all internal repeat motifs are present in all groups. In addition, they considered the evolutionary history of the VNTR. The sequence is present in no more than a single copy in our bonobo, chimpanzee, gorilla, and orangutan cousins, so the repeat expansion appears to be specific to the human lineage. However, it appears in expanded form in Neanderthal and Denisovan genomes, so it must have begun expanding before the emergence of modern humans.

Evolutionary History of VNTRs

What This Means for the Future

“This is a really neat example of what so often happens in science, starting in one place and ending up somewhere else,” Course says. “We started out looking at something that was involved in disease and were surprised to find ourselves moving into population genetics and evolution.”

Valdmanis and his team hope that this study encourages other scientists to explore their VNTRs of interest with PacBio long-read sequencing. For their part, they plan to continue on this path in addition to their ongoing focus on understanding the role of the WDR7 repeat in sporadic ALS. “Now that we have a pipeline established and know how to amplify and understand the individual variation in repeats, we’re taking a look at other repeats that seem to have extended in a similar manner after the primate split,” he says. “We can use this technology to evaluate how repeats expand across the genome.”

It promises to be a fruitful quest. After all, tandem repeats appear to have strong association with diseases, particularly neurological ones. Many human-specific VNTRs are involved in synaptic transmission. “If we look at human-specific tandem repeats, these are areas of the genome that evolved fairly recently” — such as the brain, Course notes.

“These are genes that potentially could have expanded as drivers of evolution,” Valdmanis adds. “Perhaps the brain has an increased propensity for somatic expansion.”

Want to Use HiFi Reads in Your Research?
Connect with a PacBio Scientist

Featured Neuroscience Content

Scientists Use HiFi Sequencing to Discover Variants Linked to ALS

 

Every May is ALS Awareness Month, and we’re hoping to help by spotlighting two deserving publications from scientists at the University of Washington and at the Mayo Clinic.Read Post

Raising Awareness for Ataxia & Understanding the Disease Mechanism

 

There are several hereditary ataxias, and genetic testing is increasingly useful for pinpointing the exact type affecting a patient.Read Article

No-Amp Targeted Sequencing With PacBio SMRT Technology

 

PacBio No-Amp targeted sequencing uses the CRISPR-Cas9 system and enables scientists to access previously unsequencable regions of the genome.Learn More